STOCK TITAN

Compass Lexecon Adds Healthcare Economist Matthew Grennan

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

FTI Consulting (NYSE: FCN) announced the appointment of Matthew Grennan as an affiliate to its subsidiary Compass Lexecon. Based in Atlanta, Dr. Grennan is an Associate Professor of Economics at Emory University, specializing in empirical and theoretical industrial organization models for healthcare and life-science markets competition analysis.

Dr. Grennan brings expertise in healthcare economics, having served as an expert witness in high-profile healthcare matters. His research focuses on price transparency, physician-industry relationships, product regulation, and antitrust. He is a Research Associate at the National Bureau of Economic Research and an Editor at the Journal of Political Economy Microeconomics.

Loading...
Loading translation...

Positive

  • Strategic expansion of healthcare expertise
  • Addition of experienced expert witness in healthcare matters
  • Enhanced capabilities in healthcare economics consulting

Negative

  • None.

News Market Reaction 1 Alert

+0.06% News Effect

On the day this news was published, FCN gained 0.06%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

WASHINGTON, March 05, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the continued investment in the firm’s subsidiary Compass Lexecon with the appointment of Matthew Grennan as an affiliate.

Dr. Grennan, who is based in Atlanta, is an Associate Professor of Economics at Emory University. He specializes in using empirical and theoretical industrial organization models to analyze competition and innovation in healthcare and life-science markets.

Dr. Grennan has served as an expert witness, providing verbal and written testimony in numerous high-profile healthcare matters. His work informs business strategy and policy debates regarding price transparency, relationships between physicians and industry, regulation of new products, and antitrust. He also examines how complex incentives and imperfect information affect how health technologies are developed, adopted and priced.

“The healthcare industry has experienced major disruptions over the last few years, from the COVID-19 pandemic and the rise of telemedicine to the implementation of new technologies,” said Daniel R. Fischel, Chairman of Compass Lexecon. “Matthew adds great value to the firm in the healthcare economics and related fields and strengthens our top-notch roster of affiliates that can provide data-driven solutions to clients.”

Dr. Grennan is a Research Associate at the National Bureau of Economic Research and an Editor at the Journal of Political Economy Microeconomics. He has received research grants from the National Science Foundation and the National Institute for Health Care Management.

Commenting on his affiliation with Compass Lexecon, Dr. Grennan said, “I look forward to collaborating with the Compass Lexecon team to provide the highest level of service to their clients navigating complex economic issues.”

About FTI Consulting   
FTI Consulting, Inc. is a leading global expert firm for organizations facing crisis and transformation, with more than 8,300 employees in 34 countries and territories as of December 31, 2024. The Company generated $3.69 billion in revenues during fiscal year 2024. In certain jurisdictions, FTI Consulting’s services are provided through distinct legal entities that are separately capitalized and independently managed. More information can be found at www.fticonsulting.com.  

FTI Consulting, Inc.  
555 12th Street NW  
Washington, DC 20004  
+1.202.312.9100 

Investor Contact:  
Mollie Hawkes 
+1.617.747.1791 
mollie.hawkes@fticonsulting.com 

Media Contact:  
Matthew Bashalany 
+1.617.897.1545 
matthew.bashalany@fticonsulting.com 


FAQ

What expertise does Matthew Grennan bring to Compass Lexecon's healthcare practice?

Dr. Grennan brings expertise in healthcare economics, empirical and theoretical industrial organization models, and experience as an expert witness in healthcare matters, focusing on price transparency and industry regulations.

How will FCN's Compass Lexecon benefit from Matthew Grennan's appointment?

The appointment strengthens Compass Lexecon's healthcare economics capabilities, adding expertise in analyzing competition, innovation, and providing data-driven solutions to clients in healthcare markets.

What are Matthew Grennan's current academic positions and affiliations?

He is an Associate Professor of Economics at Emory University, a Research Associate at the National Bureau of Economic Research, and an Editor at the Journal of Political Economy Microeconomics.

What healthcare market challenges does FCN's new affiliate address?

Dr. Grennan addresses challenges in price transparency, physician-industry relationships, product regulation, antitrust, and how complex incentives affect health technology development and pricing.
Fti Consulting Inc

NYSE:FCN

FCN Rankings

FCN Latest News

FCN Latest SEC Filings

FCN Stock Data

5.39B
30.26M
1.84%
104.38%
4.32%
Consulting Services
Services-management Consulting Services
Link
United States
WASHINGTON